News from ptc therapeutics, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 23, 2015, 14:53 ET

PTC Therapeutics' CEO Stuart W. Peltz, Ph.D. Finalist For The 2015 NJBiz Innovation Hero Award

Please replace the press release from June 23rd, 10:30 am ET with the following corrected version. The corrected version reads: PTC Therapeutics'...

Jun 15, 2015, 08:00 ET

PTC Therapeutics Appoints Glenn D. Steele Jr., M.D., Ph.D. to Board of Directors

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Glenn D. Steele Jr., M.D., Ph.D. to the company's Board of Directors. Dr....

Jun 12, 2015, 16:30 ET

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 9, 2015 it approved non-statutory stock options to purchase an aggregate of...

Jun 12, 2015, 08:00 ET

PTC Therapeutics and BioMarin Pharmaceutical to Host DMD Industry Symposium

 PTC Therapeutics, Inc. (NASDAQ: PTCT) and BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that they will host an Industry Update...

May 21, 2015, 16:01 ET

German Federal Joint Committee Issues Positive Medical Benefit Rating for Translarna™ in Patients with Nonsense Mutation Duchenne Muscular Dystrophy

 PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced that the Benefit Assessment by Germany's Federal Joint Committee (G-BA) indicated that...

May 15, 2015, 17:58 ET

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on May 15, 2015 it approved non-statutory stock options to purchase an aggregate of...

May 11, 2015, 08:00 ET
PTC Therapeutics logo.

PTC Therapeutics Launches STRIVE Grant Award Program

SOUTH PLAINFIELD, N.J., May 11, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced it has launched STRIVE (Strategies to...

May 04, 2015, 16:05 ET

PTC Therapeutics Reports First Quarter 2015 Financial Results and Provides Corporate Update

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the first quarter ending March 31,...

Apr 28, 2015, 08:00 ET

PTC Therapeutics' Cancer Stem Cell Program Targeting BMI1 Enters Phase 1

PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced that its oncology program targeting BMI1, a protein linked to drug-resistant cancers, has...

Apr 23, 2015, 08:00 ET

PTC Therapeutics to Participate at Upcoming Investor Conferences

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: -...

Apr 20, 2015, 08:02 ET

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2015 Financial Results

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2015...

Apr 20, 2015, 08:00 ET

Phase 1 Data from Spinal Muscular Atrophy Program to be Presented at the 2015 American Academy of Neurology Annual Meeting

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Phase 1 clinical data from the company's joint development program with Roche and...

Apr 10, 2015, 16:31 ET

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 7, 2015 it approved non-statutory stock options to purchase an aggregate of...

Apr 08, 2015, 08:00 ET

PTC Therapeutics Names Eric Pauwels SVP & General Manager Commercial Operations, Americas

SOUTH PLAINFIELD, N.J., April 8, 2015 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced the appointment of Eric Pauwels as...

Mar 19, 2015, 08:00 ET

PTC Therapeutics and University of Pennsylvania Collaborate on Orphan Disease Research

 PTC Therapeutics, Inc. (Nasdaq: PTCT) today announced a collaboration with the Orphan Disease Center at the Perelman School of Medicine at the...

Mar 03, 2015, 08:00 ET

PTC Announces Translarna™ Access Program In Duchenne Muscular Dystrophy for Siblings of Patients Participating in PTC Clinical Trials

 PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced that it will make Translarna available for siblings of patients in certain open label...

Feb 27, 2015, 08:00 ET

PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the fourth quarter and full year...

Feb 16, 2015, 08:00 ET

PTC Therapeutics to Participate at Upcoming March Investor Conferences

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: -...

Feb 13, 2015, 16:30 ET

PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2014 Financial Results

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to discuss fourth quarter and year...

Feb 06, 2015, 17:00 ET

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

 PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on February 6, 2015 it approved non-statutory stock options to purchase an...